MENU

Facing Triple Negative Breast Cancer

With a strong family history of breast cancer, Linda knew she was at a high risk of getting the disease. So, Linda went on the offense, taking difficult steps to reduce her breast cancer risk. But even after these dramatic precautions, Linda still received a shocking diagnosis – triple negative breast cancer. A fighter by nature, Linda stood up to her cancer and inspired others to do the same.

Fox Chase-Temple BMT Program Named a Blue Distinction Center

Temple University Hospital earned the status of a “Blue Distinction Center for Transplants” by Blue Cross Blue Shield, in recognition of the Fox Chase-Temple University Hospital Bone Marrow Transplant (BMT) Program’s expertise in performing adult bone marrow transplants. The Fox Chase-Temple BMT Program has performed more than 1,500 transplants.

Translational Medicine

Translational medicine brings new diagnostic and prognostic biomarkers, as well as devices and therapeutics, to positively impact the lives of people at risk of cancer as well as patients with cancer. Translational research disease groups (TRDGs) coordinate assessment of research opportunities, particularly through investigator-initiated trials, interdisciplinary collaboration, research support, and trainee involvement.